Director John E. Lynch passes away; Jim Moran appointed to Audit and Compensation Committees

IGC Pharma, Inc.

John E. Lynch, director since Jan 11, 2021, passed away on Dec 24, 2022.
Former Congressman Jim Moran (director since Jan 18, 2022) appointed to Audit and Compensation Committees effective Dec 27.
Richard Prins remains Chairman of Board, Audit and Compensation Committees, and Audit financial expert.
Board continues with three independent directors: Prins, Moran, and one unnamed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John E. Lynch

Director

IGC · IGC Pharma, Inc.

Effective: 2022-12-24
Filed: December 29, 2022, 6:59 PM ET

On December 24, 2022, John E. Lynch, a Director of India Globalization Capital Inc. (the “Company” or “IGC”), passed away.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John E. Lynch departed as Director at IGC Pharma, Inc..

Action: passed away
Role: Director

Exact text from the filing

On December 24, 2022, John E. Lynch, a Director of India Globalization Capital Inc. (the “Company” or “IGC”), passed away.

View on SEC.gov

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-22-001458

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.